NR3C1 and precursor B-cell acute lymphoblastic leukemia: In pediatric B-ALL, Carroll et al. identified a relapse-specific gene expression signature characterized by upregulation of BIRC5, FOXM1, FANCD2, and TYMS, and downregulation of NR3C1, HRK, and SMEK2 [38].